Mark A. Terry
Research Subjects
Mark A. Terry has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Neda Shamie
9 shared publications- Jeffrey M. Goshe
Devers Eye Institute, Portland, Oregon 97210, USA
5 shared publications Daniel J. Friend
4 shared publicationsDavid Davis-Boozer
4 shared publicationsKaren L. Hoar
4 shared publicationsEdwin S Chen
From the *Devers Eye Institute, Portland, OR; †Lions Vision Research Laboratory of Oregon, Portland, OR; ‡Lions Eye Bank of Oregon, Portland, OR; and §Tanta Faculty of Medicine, Tanta, Egypt
3 shared publications
Latest Publications
- 28 September 2020
- Published by Wolters Kluwer Health in Cornea
- Vol. 40 (9) , 1087-1088
The Role of Donor Rim Fungal Cultures
Culturing all donor rims for fungus makes no sense. Only 1% of all cultures will be positive, and of those positive cultures, only 6% will also have a clinical infection. Prophylactically treating all positive cultures means 94% of patients will be treated unnecessarily. Fungal cultures do not reliably direct specific medication choice, and fungal infections of the interface in endothelial keratoplasty and deep anterior lamellar keratoplasty are nearly impervious to medical therapy. Suspected fungal infections of the deep stromal interface should be treated expeditiously with penetrating keratoplasty before peripheral spread or endophthalmitis occur.
- 28 September 2020
- Published by Wolters Kluwer Health in Cornea
- Vol. 40 (9) , 1087-1088
The Role of Donor Rim Fungal Cultures
Culturing all donor rims for fungus makes no sense. Only 1% of all cultures will be positive, and of those positive cultures, only 6% will also have a clinical infection. Prophylactically treating all positive cultures means 94% of patients will be treated unnecessarily. Fungal cultures do not reliably direct specific medication choice, and fungal infections of the interface in endothelial keratoplasty and deep anterior lamellar keratoplasty are nearly impervious to medical therapy. Suspected fungal infections of the deep stromal interface should be treated expeditiously with penetrating keratoplasty before peripheral spread or endophthalmitis occur.
- Open Access
- 1 January 2019
- Published by Medknow in Taiwan Journal of Ophthalmology
- Vol. 9 (1) , 18-26
Step-by-step Descemet's membrane endothelial keratoplasty surgery
With the success of Descemet stripping automated endothelial keratoplasty (DSAEK) technique providing better outcomes in visual prognosis and theoretically lower rejection rate than penetrating keratoplasty, DSAEK dominated the realm of endothelial keratoplasty for the past decade. However, Descemet membrane endothelial keratoplasty (DMEK) has become more and more popular worldwide due to its even lower rejection rate, faster visual recovery, better visual outcome, and lower long-term endothelial loss. In this article, we demonstrate the techniques and nuances of DMEK surgery in detail for corneal specialists who are beginning their DMEK surgeries.
- 1 January 2019
- Published by Medknow in Taiwan Journal of Ophthalmology
- Vol. 9 (1) , 18-26
Open AccessStep-by-step Descemet's membrane endothelial keratoplasty surgery
With the success of Descemet stripping automated endothelial keratoplasty (DSAEK) technique providing better outcomes in visual prognosis and theoretically lower rejection rate than penetrating keratoplasty, DSAEK dominated the realm of endothelial keratoplasty for the past decade. However, Descemet membrane endothelial keratoplasty (DMEK) has become more and more popular worldwide due to its even lower rejection rate, faster visual recovery, better visual outcome, and lower long-term endothelial loss. In this article, we demonstrate the techniques and nuances of DMEK surgery in detail for corneal specialists who are beginning their DMEK surgeries.
- 12 April 2017
- Published by Wolters Kluwer Health in Cornea
- Vol. 36 (6) , 661-664
Intraoperative S-Stamp Enabled Rescue of 3 Inverted Descemet Membrane Endothelial Keratoplasty Grafts
To report the clinical outcomes of 3 Descemet membrane endothelial keratoplasty (DMEK) grafts, in which an upside down DMEK graft orientation was discovered after SF6 gas insufflation of the anterior chamber and the orientation was then corrected intraoperatively. A total of 371 consecutive DMEK cases using an S-stamp were analyzed and found to include 3 cases in which the DMEK graft was initially elevated with SF6 gas in an upside down orientation, as demonstrated intraoperatively by the S-stamp. In each case, the graft was immediately manipulated into the proper orientation and the rescued case completed using our standard technique. The postoperative complications of these cases were reported and the percentage of endothelial cell loss at 6 months was compared with that of cases in this series without this rare intraoperative complication. All 3 rescued grafts achieved successful recipient corneal clearance and improved vision for the patient. There was no graft failure, rebubble, or rejection in these 3 cases. The average 6-month endothelial cell loss in the 3 initially inverted grafts was 51%, 58.3%, and 67% compared with 31.6% (SD ± 17.4%) in the series at large. Incorporation of a stromal-sided S-stamp has been previously shown to reduce the risk of iatrogenic primary graft failure through the prevention of upside down graft implantation. In these 3 instances, although the stamp did not prevent initial upside down graft elevation, it did allow the surgeon to immediately recognize this rare problem, correct it intraoperatively, and prevent iatrogenic graft failure in each case.
- 12 April 2017
- Published by Wolters Kluwer Health in Cornea
- Vol. 36 (6) , 661-664
Intraoperative S-Stamp Enabled Rescue of 3 Inverted Descemet Membrane Endothelial Keratoplasty Grafts
To report the clinical outcomes of 3 Descemet membrane endothelial keratoplasty (DMEK) grafts, in which an upside down DMEK graft orientation was discovered after SF6 gas insufflation of the anterior chamber and the orientation was then corrected intraoperatively. A total of 371 consecutive DMEK cases using an S-stamp were analyzed and found to include 3 cases in which the DMEK graft was initially elevated with SF6 gas in an upside down orientation, as demonstrated intraoperatively by the S-stamp. In each case, the graft was immediately manipulated into the proper orientation and the rescued case completed using our standard technique. The postoperative complications of these cases were reported and the percentage of endothelial cell loss at 6 months was compared with that of cases in this series without this rare intraoperative complication. All 3 rescued grafts achieved successful recipient corneal clearance and improved vision for the patient. There was no graft failure, rebubble, or rejection in these 3 cases. The average 6-month endothelial cell loss in the 3 initially inverted grafts was 51%, 58.3%, and 67% compared with 31.6% (SD ± 17.4%) in the series at large. Incorporation of a stromal-sided S-stamp has been previously shown to reduce the risk of iatrogenic primary graft failure through the prevention of upside down graft implantation. In these 3 instances, although the stamp did not prevent initial upside down graft elevation, it did allow the surgeon to immediately recognize this rare problem, correct it intraoperatively, and prevent iatrogenic graft failure in each case.
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery Online Case Reports
- Vol. 3 (4) , 75-77
Immunologic perspective on the denuded stromal “gutter” after Descemet membrane endothelial keratoplasty
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery Online Case Reports
- Vol. 3 (4) , 75-77
Immunologic perspective on the denuded stromal “gutter” after Descemet membrane endothelial keratoplasty
- 1 July 2013
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 156 (1) , 61-68.e3
Endothelial Keratoplasty: Prospective, Randomized, Masked Clinical Trial Comparing an Injector With Forceps for Tissue Insertion
- 1 July 2013
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 156 (1) , 61-68.e3
Endothelial Keratoplasty: Prospective, Randomized, Masked Clinical Trial Comparing an Injector With Forceps for Tissue Insertion
- 1 October 2012
- Published by Elsevier in Ophthalmology
- Vol. 119 (10) , 1988-1996
Descemet's Stripping Automated Endothelial Keratoplasty: The Tenuous Relationship between Donor Thickness and Postoperative Vision
- 1 October 2012
- Published by Elsevier in Ophthalmology
- Vol. 119 (10) , 1988-1996
Descemet's Stripping Automated Endothelial Keratoplasty: The Tenuous Relationship between Donor Thickness and Postoperative Vision
- 31 July 2012
- Published by Elsevier in Ophthalmology
- Vol. 119 (7) , 1499
Author reply
- 1 May 2012
- Published by Wolters Kluwer Health in Cornea
- Vol. 31 (5) , 469-471
Endothelial Keratoplasty
- 1 May 2012
- Published by Wolters Kluwer Health in Cornea
- Vol. 31 (5) , 469-471
Endothelial Keratoplasty
- 1 October 2011
- Published by Elsevier in Ophthalmology
- Vol. 118 (10) , 1944-1949
Endothelial Keratoplasty: The Relationship between Donor Tissue Size and Donor Endothelial Survival
- 1 October 2011
- Published by Elsevier in Ophthalmology
- Vol. 118 (10) , 1944-1949
Endothelial Keratoplasty: The Relationship between Donor Tissue Size and Donor Endothelial Survival